Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 27;16(1):128.
doi: 10.1186/s12866-016-0742-3.

Auxotrophic Actinobacillus pleurpneumoniae grows in multispecies biofilms without the need for nicotinamide-adenine dinucleotide (NAD) supplementation

Affiliations

Auxotrophic Actinobacillus pleurpneumoniae grows in multispecies biofilms without the need for nicotinamide-adenine dinucleotide (NAD) supplementation

Abraham Loera-Muro et al. BMC Microbiol. .

Abstract

Background: Actinobacillus pleuropneumoniae is the etiologic agent of porcine contagious pleuropneumonia, which causes important worldwide economic losses in the swine industry. Several respiratory tract infections are associated with biofilm formation, and A. pleuropneumoniae has the ability to form biofilms in vitro. Biofilms are structured communities of bacterial cells enclosed in a self-produced polymer matrix that are attached to an abiotic or biotic surface. Virtually all bacteria can grow as a biofilm, and multi-species biofilms are the most common form of microbial growth in nature. The goal of this study was to determine the ability of A. pleuropneumoniae to form multi-species biofilms with other bacteria frequently founded in pig farms, in the absence of pyridine compounds (nicotinamide mononucleotide [NMN], nicotinamide riboside [NR] or nicotinamide adenine dinucleotide [NAD]) that are essential for the growth of A. pleuropneumoniae.

Results: For the biofilm assay, strain 719, a field isolate of A. pleuropneumoniae serovar 1, was mixed with swine isolates of Streptococcus suis, Bordetella bronchiseptica, Pasteurella multocida, Staphylococcus aureus or Escherichia coli, and deposited in 96-well microtiter plates. Based on the CFU results, A. pleuropneumoniae was able to grow with every species tested in the absence of pyridine compounds in the culture media. Interestingly, A. pleuropneumoniae was also able to form strong biofilms when mixed with S. suis, B. bronchiseptica or S. aureus. In the presence of E. coli, A. pleuropneumoniae only formed a weak biofilm. The live and dead populations, and the matrix composition of multi-species biofilms were also characterized using fluorescent markers and enzyme treatments. The results indicated that poly-N-acetyl-glucosamine remains the primary component responsible for the biofilm structure.

Conclusions: In conclusion, A. pleuropneumoniae apparently is able to satisfy the requirement of pyridine compounds through of other swine pathogens by cross-feeding, which enables A. pleuropneumoniae to grow and form multi-species biofilms.

Keywords: Actinobacillus pleuropneumoniae; Biofilms; Bordetella bronchiseptica; Escherichia coli; Pasteurella multocida; Pyridine compounds; Staphylococcus aureus; Streptococcus suis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multi-species biofilms formation by A. pleuropneumoniae with other swine pathogens. A. pleuropneumoniae, S. suis, B. bronchiseptica, P. multocida, S. aureus and E. coli. The biofilms grown as (a) single, (b) dual or (c) triple-species biofilms in BHI media with or without NAD, they were stained with crystal violet staining. The colony forming units (CFU) of A. pleuropneumoniae and the other bacteria were enumerated from multi-species biofilms grown in BHI media with or without NAD grown as (d) single, (e) two or (f) three-species biofilms. App: A. pleuropneumoniae; Ss: S. suis; Bb: B. bronchiseptica; Pm: P. multocida; Sa: S. aureus; Ec: E. coli
Fig. 2
Fig. 2
Effect of enzymatic treatment on multi-species biofilms. Dispersion by (a) proteinase K, (b) DNase I, and (c) dispersin B of multi-species biofilms formed by A. pleuropneumoniae, S. suis, B. bronchiseptica, P. multocida, S. aureus and E. coli grown in BHI media with or without NAD. App: A. pleuropneumoniae; Ss: S. suis; Bb: B. bronchiseptica; Pm: P. multocida; Sa: S. aureus; Ec: E. coli. * p < 0.05
Fig. 3
Fig. 3
CLSM of multi-species biofilms of A. pleuropneumoniae with other swine pathogens without NAD supplementation. A. pleuropneumoniae, S. suis, B. bronchiseptica, P. multocida, S. aureus and E. coli grown as single, dual or triple-species biofilms in BHI media without NAD stained with FM 1-43, SYTO 9, propidium iodide, wheat-germ agglutinin (WGA)-Oregon green, BOBO-3, and SYPRO Ruby (all from Invitrogen, Eugene, OR). PGA: poly-N-acetylglucosamine; eDNA: extracellular DNA; App: A. pleuropneumoniae; Ss: S. suis; Bb: B. bronchiseptica; Pm: P. multocida; Sa: S. aureus; Ec: E. coli. Scale bar 30 μm
Fig. 4
Fig. 4
Confirmation of the presence of A. pleuropneumoniae in multi-species biofilms. Confirmation of A. pleuropneumoniae in the dual-species biofilm of A. pleuropneumoniae 719 and S. suis 735 or B. bronchiseptica 276 by FISH with an ApxIVAN-AlexaFluor 633 probe (red). Images of the X-Z plane of biofilm of single and dual-species biofilms grown in BHI with or without NAD. Bacterial cell in the biofilms were stained with FilmTracer ™ FM ® 1-43 (Molecular Probes) which are represented in green. Yellow represent the co-localization of both the ApxIVAN probe and the stain FM 1-43. App: A. pleuropneumoniae; Ss: S. suis; Bb: B. bronchiseptica
Fig. 5
Fig. 5
3D models of A. pleuropneumoniae in multi-species biofilms. Duals-species biofilms of (a) A. pleuropneumoniae 719 and S. suis 735 or (b) A. pleuropneumoniae 719 and B. bronchiseptica 276 detected with ApxIVAN-AlexaFluor 633 probe (red). Bacterial cell in the biofilms were stained with FilmTracer ™ FM ® 1-43 (Molecular Probes) which are represented in green. Yellow represent the co-localization of both the ApxIVAN probe and FM 1-43

Similar articles

Cited by

References

    1. Brockmeier S, Halbur P, Thacker, E. Porcine Respiratory Disease Complex. In: Brogden K, Guthmiller J, editors. Polymicrobial Diseases. ASM Press: American Society for Microbiology; 2002;231-58.
    1. Ramjeet M, Cox A, Hancock M, Mourez M, Labrie J, et al. Mutation in the LPS outer core biosynthesis gene, galU, affects LPS interaction with the RTX toxins ApxI and ApxII and cytolytic activity of Actinobacillus pleuropneumoniae serovar 1. Mol Microbiol. 2008;70:221–235. doi: 10.1111/j.1365-2958.2008.06409.x. - DOI - PubMed
    1. Auger E, Deslandes V, Ramjeet M, Contreras I, Nash J, et al. Host Pathogen Interactions of Actinobacillus pleuropneumoniae with Porcine Lung and Tracheal Epithelial Cells. Infect Immun. 2009;77:1426–1441. doi: 10.1128/IAI.00297-08. - DOI - PMC - PubMed
    1. Buettner F, Konze S, Maas A, Gerlach G. Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae. Proteome Sci. 2011;9:1–23. doi: 10.1186/1477-5956-9-23. - DOI - PMC - PubMed
    1. Li L, Xu Z, Zhou Y, Li T, Sun L, et al. Analysis on Actinobacillus pleuropneumoniae LuxS regulated genes reveals pleiotropic roles of LuxS/AI-2 on biofilm formation, adhesion ability and iron metabolism. Microb Pathog. 2011;50:293–302. doi: 10.1016/j.micpath.2011.02.002. - DOI - PubMed

MeSH terms

LinkOut - more resources